These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 9680262
1. Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine. Terry AV, Williamson R, Gattu M, Beach JW, McCurdy CR, Sparks JA, Pauly JR. Neuropharmacology; 1998; 37(1):93-102. PubMed ID: 9680262 [Abstract] [Full Text] [Related]
2. Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes. Miller DK, Crooks PA, Dwoskin LP. Neuropharmacology; 2000 Oct; 39(13):2654-62. PubMed ID: 11044735 [Abstract] [Full Text] [Related]
3. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Clarke PB, Reuben M. Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402 [Abstract] [Full Text] [Related]
4. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors. Rao TS, Correa LD, Lloyd GK. Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640 [Abstract] [Full Text] [Related]
5. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters. Miller DK, Crooks PA, Zheng G, Grinevich VP, Norrholm SD, Dwoskin LP. J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762 [Abstract] [Full Text] [Related]
6. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake. Teng L, Crooks PA, Sonsalla PK, Dwoskin LP. J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333 [Abstract] [Full Text] [Related]
10. Differential mechanisms involved in the effect of nicotinic agonists DMPP and lobeline to release [3H]5-HT from rat hippocampal slices. Lendvai B, Sershen H, Lajtha A, Santha E, Baranyi M, Vizi ES. Neuropharmacology; 1996 Mar; 35(12):1769-77. PubMed ID: 9076756 [Abstract] [Full Text] [Related]
11. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S. J Pharmacol Exp Ther; 2002 Jul; 302(1):197-204. PubMed ID: 12065717 [Abstract] [Full Text] [Related]
14. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity. Sumithran SP, Crooks PA, Xu R, Zhu J, Deaciuc AG, Wilkins LH, Dwoskin LP. AAPS J; 2005 Aug 29; 7(1):E201-17. PubMed ID: 16146341 [Abstract] [Full Text] [Related]
15. Regulation of brain nicotinic receptors by chronic agonist infusion. Bhat RV, Turner SL, Selvaag SR, Marks MJ, Collins AC. J Neurochem; 1991 Jun 29; 56(6):1932-9. PubMed ID: 2027007 [Abstract] [Full Text] [Related]
16. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. Clarke PB, Reuben M, el-Bizri H. Br J Pharmacol; 1994 Mar 29; 111(3):695-702. PubMed ID: 8019748 [Abstract] [Full Text] [Related]